WAM
LIMNW

Wolverine Asset Management’s Liminatus Pharma Warrants LIMNW Stock Holding History

Wolverine Asset Management’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57K Sell
39,373
-23,422
-37% -$1.5K ﹤0.01% 1575
2025
Q4 		$2.2K Sell
62,795
-68
-0.1% -$7 ﹤0.01% 1534
2025
Q3 		$9.3K Sell
62,863
-40,124
-39% -$7.83K ﹤0.01% 1376
2025
Q2 		$24.7K Buy
+102,987
New +$20.2K ﹤0.01% 1291

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wolverine Asset Management's LIMNW Position: Q1 2026 in Review

Wolverine Asset Management reduced its Liminatus Pharma Warrants (LIMNW) stake by 37% in Q1 2026, selling an estimated $1.5K and leaving 39,373 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Wolverine Asset Management first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $24.7K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • Wolverine Asset Management held 39,373 shares of Liminatus Pharma Warrants worth $1.57K as of Q1 2026.
  • Wolverine Asset Management sold 23,422 Liminatus Pharma Warrants shares in Q1 2026, an estimated $1.5K.
  • Liminatus Pharma Warrants made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1575 holding.
  • Wolverine Asset Management first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • Wolverine Asset Management's Liminatus Pharma Warrants position peaked at $24.7K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.